- £10.13m
- £8.24m
- £26.69m
- 42
- 77
- 55
- 60
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23.5 | 33 | 31.8 | 35.9 | 26.7 |
Cost of Revenue | |||||
Gross Profit | 6.83 | 10.2 | 9.89 | 10.8 | 6.45 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 30.2 | 33.7 | 31.5 | 34.8 | 36.2 |
Operating Profit | -6.72 | -0.71 | 0.231 | 1.05 | -9.56 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.88 | -1.26 | 0.033 | 0.936 | -9.63 |
Provision for Income Taxes | |||||
Net Income After Taxes | -5.86 | -1.5 | 0.145 | -0.292 | -8.18 |
Net Income Before Extraordinary Items | |||||
Net Income | -5.86 | -1.5 | 0.145 | -0.292 | -8.18 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -5.86 | -1.5 | 0.145 | -0.292 | -8.18 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.244 | -0.048 | 0.006 | -0.012 | -0.176 |